The use of flow cytometry to detect antiviral resistance in human cytomegalovirus

被引:13
作者
Kesson, AM
Zeng, F
Cunningham, AL
Rawlinson, WD
机构
[1] Univ Newcastle, Fac Med & Hlth Sci, Discipline Pathol, Newcastle, NSW 2305, Australia
[2] Univ Newcastle, Dept Microbiol & Infect Dis, Hunter Area Pathol Serv, Newcastle, NSW 2305, Australia
[3] Westmead Hosp, Westmead Inst Hlth Res, Ctr Viral Res, Westmead, NSW 2145, Australia
[4] Dept Microbiol, Div Virol, Randwick, NSW 2031, Australia
关键词
human cytomegalovirus; cytometry; ganciclovir;
D O I
10.1016/S0166-0934(97)00214-0
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A method for detecting the antiviral susceptibility of human cytomegalovirus (HCMV) isolates to antiviral agents using flow cytometry was developed. This method has been used to detect the resistance phenotype of HCMV isolates to ganciclovir (GCV). The procedure involves infecting MRC-5 cells with 10(4) pfu HCMV for 120 h, then fixing and permeabilising the cells to allow intracellular labelling of the HCMV early and late antigens. The percentage reduction in the fluorescence positive population of HCMV-infected MRC-5 cells treated with GCV at concentrations of 20 or 50 mu M compared with control cultures without GCV was determined. The IC50 defined as a < 50% reduction in the fluorescence positive population in cells infected in the presence of 20 mu M GCV or an IC90 defined as a < 90% reduction in the fluorescence-positive population in cells infected in the presence of 50 mu M GCV, correlated with resistance determined by a plaque reduction assay. The FACS assay is a rapid and reproducible method for detecting antiviral resistance of HCMV. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:177 / 186
页数:10
相关论文
共 10 条
[1]   A HUMAN CYTOMEGALOVIRUS MUTANT RESISTANT TO THE NUCLEOSIDE ANALOG 9-([2-HYDROXY-1-(HYDROXYMETHYL)ETHOXY]METHYL)GUANINE (BW B759U) INDUCES REDUCED LEVELS OF BW B759U TRIPHOSPHATE [J].
BIRON, KK ;
FYFE, JA ;
STANAT, SC ;
LESLIE, LK ;
SORRELL, JB ;
LAMBE, CU ;
COEN, DM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (22) :8769-8773
[2]   RAPID ANTIVIRAL DNA-DNA HYBRIDIZATION ASSAY FOR HUMAN CYTOMEGALOVIRUS [J].
DANKNER, WM ;
SCHOLL, D ;
STANAT, SC ;
MARTIN, M ;
SONKE, RL ;
SPECTOR, SA .
JOURNAL OF VIROLOGICAL METHODS, 1990, 28 (03) :293-298
[3]   PREVALENCE OF RESISTANCE IN PATIENTS RECEIVING GANCICLOVIR FOR SERIOUS CYTOMEGALOVIRUS-INFECTION [J].
DREW, WL ;
MINER, RC ;
BUSCH, DF ;
FOLLANSBEE, SE ;
GULLETT, J ;
MEHALKO, SG ;
GORDON, SM ;
OWEN, WF ;
MATTHEWS, TR ;
BUHLES, WC ;
DEARMOND, B .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (04) :716-719
[4]   PROGRESSIVE DISEASE DUE TO GANCICLOVIR-RESISTANT CYTOMEGALO-VIRUS IN IMMUNOCOMPROMISED PATIENTS [J].
ERICE, A ;
CHOU, S ;
BIRON, KK ;
STANAT, SC ;
BALFOUR, HH ;
JORDAN, MC .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (05) :289-293
[5]   MONITORING OF GANCICLOVIR SENSITIVITY OF MULTIPLE HUMAN CYTOMEGALOVIRUS STRAINS COINFECTING BLOOD OF AN AIDS PATIENT BY AN IMMEDIATE-EARLY ANTIGEN PLAQUE-ASSAY [J].
GERNA, G ;
BALDANTI, F ;
ZAVATTONI, M ;
SARASINI, A ;
PERCIVALLE, E ;
REVELLO, MG .
ANTIVIRAL RESEARCH, 1992, 19 (04) :333-345
[6]  
LURAIN N, 1977, CLIN MICROBIOL NEWSL, V19, P41
[7]  
MAHY BWJ, 1985, VIROLOGY PRACTICAL A
[8]   SYNERGISTIC EFFECT OF GANCICLOVIR AND FOSCARNET ON CYTOMEGALOVIRUS REPLICATION INVITRO [J].
MANISCHEWITZ, JF ;
QUINNAN, GV ;
LANE, HC ;
WITTEK, AE .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (02) :373-375
[9]   USES OF FLOW-CYTOMETRY IN VIROLOGY [J].
MCSHARRY, JJ .
CLINICAL MICROBIOLOGY REVIEWS, 1994, 7 (04) :576-&
[10]   A GENTLE FIXATION AND PERMEABILIZATION METHOD FOR COMBINED CELL-SURFACE AND INTRACELLULAR STAINING WITH IMPROVED PRECISION IN DNA QUANTIFICATION [J].
SCHMID, I ;
UITTENBOGAART, CH ;
GIORGI, JV .
CYTOMETRY, 1991, 12 (03) :279-285